(Q33738466)

29 July 2017

1 reference

title

Antisense oligonucleotides as therapeutic agents (English)

1 reference

29 July 2017

3

1 reference

29 July 2017

Galderisi U

1

1 reference

29 July 2017

Cascino A

series ordinal

2

1 reference

29 July 2017

publication date

1 November 1999

1 reference

Journal of Cellular Physiology

29 July 2017

published in

1 reference

29 July 2017

volume

181

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

251-257

1 reference

Antisense oligonucleotides: towards clinical trials

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Modified oligonucleotides as therapeutic and diagnostic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Progress in antisense oligonucleotide therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Cell cycle: molecular targets for diagnosis and therapy: tumor suppressor genes and cell cycle progression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antisense raf oligodeoxyribonucleotide is protected by liposomal encapsulation and inhibits Raf-1 protein expression in vitro and in vivo: implication for gene therapy of radioresistant cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antiviral Potency of Drug—Gene Therapy Combinations against Human Immunodeficiency Virus Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Cell cycle targets of Ras/Raf signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antisense strategies for the treatment of hematological malignancies and solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Vascular gene transfer for the treatment of restenosis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Characterization of oligonucleotide transport into living cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Structure of the activated c-raf-1 gene from human stomach cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

MYC oncogenes and human neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antisense therapy of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

21 January 2018

Bcl-2 family proteins

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Inhibition of HIV replication by immunoliposomal antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

21 January 2018

Does antisense exist?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

The state of the art in antisense research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Antisense technology and prospects for therapy of viral infections and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Development of an in vitro model of tumor progression using v-raf and v-raf/v-myc transformed rat liver epithelial cells: correlation of tumorigenicity with the downregulation of specific proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Treatment of duck hepatitis B virus by antisense poly-2'-O-(2,4-dinitrophenyl)-oligoribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

The RAF family: an expanding network of post-translational controls and protein-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

Inhibition of expression of PKC-alpha by antisense mRNA is associated with diminished cell growth and inhibition of amylase secretion by AR4-2J cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-4652%28199911%29181%3A2%3C251%3A%3AAID-JCP7%3E3.0.CO%3B2-D

10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference